Susan Shiff
Vermogen: 10 102 $ op 31-08-2026
Vermogen: 10 102 $ op 31-08-2026
Susan Patricia Shiff is currently Chief Executive Officer & Director at Huma.ai, Inc. since 2024.
She is a Director at Merck Global Health Innovation Fund LLC, Director at Synthace Ltd. since 2018, Independent Director at Tvardi Therapeutics, Inc. starting in 2025, and Trustee at New Jersey Symphony Orchestra.
Former roles include Independent Director at CARA Therapeutics, Inc., Senior Vice President at Merck & Co., Inc. from 2014 to 2021, Vice President at Pfizer Inc., Vice President-Global Health Economics at Teva Pharmaceutics, and President at Ontada LLC from 2021 to 2023.
Education includes a doctorate from the University of California, Los Angeles and an MBA from Cornell University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
0,04% | 09-06-2026 | 5.612 ( 0,04% ) | 10 102 $ | 31-08-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
Synthace Ltd.
Synthace Ltd. Packaged SoftwareTechnology Services Develops life sciences R&D cloud platform | Directeur/Bestuurslid | 05-06-2018 |
Merck Global Health Innovation Fund LLC
Merck Global Health Innovation Fund LLC Investment ManagersFinance Acts as Venture Capital Fund | Directeur/Bestuurslid | - |
New Jersey Symphony Orchestra
New Jersey Symphony Orchestra Media ConglomeratesConsumer Services Operates as non profit performing arts organization | Directeur/Bestuurslid | - |
Huma.AI, Inc.
Huma.AI, Inc. Packaged SoftwareTechnology Services Develops life sciences AI software platform for medical affairs organization | Algemeen Directeur | 01-07-2024 |
| Bedrijven | Functie | Einde |
|---|---|---|
Ontada
Ontada Medical/Nursing ServicesHealth Services Provides oncology treatment services | President | 01-07-2023 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01-03-2021 |
| PFIZER INC. | Corporate Officer/Principal | - |
Teva Pharmaceutics | Corporate Officer/Principal | - |
| CARA THERAPEUTICS, INC. | Directeur/Bestuurslid | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 11 |
|---|---|
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
CARA Therapeutics, Inc.
CARA Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes new chemical entities designed to fundamentally change the way acute pain, chronic pain and pruritus are managed | Health Technology |
University of California, Los Angeles
University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New Jersey Symphony Orchestra
New Jersey Symphony Orchestra Media ConglomeratesConsumer Services Operates as non profit performing arts organization | Consumer Services |
Teva Pharmaceutics | |
Merck Global Health Innovation Fund LLC
Merck Global Health Innovation Fund LLC Investment ManagersFinance Acts as Venture Capital Fund | Finance |
Synthace Ltd.
Synthace Ltd. Packaged SoftwareTechnology Services Develops life sciences R&D cloud platform | Technology Services |
Huma.AI, Inc.
Huma.AI, Inc. Packaged SoftwareTechnology Services Develops life sciences AI software platform for medical affairs organization | Technology Services |
Ontada
Ontada Medical/Nursing ServicesHealth Services Provides oncology treatment services | Health Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau